Revolution Medicines attracted takeover interest but decided to go it alone. This week’s FDA approval of its pancreatic cancer pill is the payoff.
Why the Drugmaker Behind a Pancreatic Cancer Breakthrough Stayed Independent
Source: WSJ Technology
The Edge of the Cyber World See the latest
Revolution Medicines attracted takeover interest but decided to go it alone. This week’s FDA approval of its pancreatic cancer pill is the payoff.
Source: WSJ Technology